(Q48209572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

title

Viruses in the treatment of malignant glioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

John Sampson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Mathias Gromeier

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

321-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17425484%20AND%20SRC:MED&resulttype=core&format=json

New approaches to primary brain tumor treatment

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Viral oncolysis by herpes simplex virus and other viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Cancer selective adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Current developments in adenovirus-based cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Targeted and shielded adenovectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Poliovirus receptor CD155-targeted oncolysis of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Structural determinants of insert retention of poliovirus expression vectors with recombinant IRES elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Intergeneric poliovirus recombinants for the treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

ReVOLT: radiation-enhanced viral oncolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Gene therapy for malignant glioma: current clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Clinical trials with retrovirus mediated gene therapy--what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Viral vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321

Recombinant viral vectors: cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.4.321